- Richard D Riley, senior lecturer in medical statistics1,
- Paul C Lambert, senior lecturer in medical statistics2,
- Ghada Abo-Zaid, postgraduate student3
- 1Department of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham B15 2TT
- 2Centre for Biostatistics and Genetic Epidemiology, Department of Health Sciences, University of Leicester, Leicester LE1 7RH
- 3School of Mathematical Sciences, University of Birmingham, Birmingham B15 2TT
- Correspondence to: R D Riley r.d.riley{at}bham.ac.uk
- Accepted 8 September 2009
Meta-analysis methods involve combining and analysing quantitative evidence from related studies to produce results based on a whole body of research. As such, meta-analyses are an integral part of evidence based medicine. Traditional methods for meta-analysis synthesise aggregate study level data obtained from study publications or study authors, such as a treatment effect estimate (for example, an odds ratio) and its associated uncertainty (for example, a standard error or confidence interval). An alternative but increasingly popular approach is meta-analysis of individual participant data, or individual patient data, in which the raw individual level data for each study are obtained and used for synthesis.1 In this article we describe the rationale for individual participant data meta-analysis and illustrate through applied examples why this strategy offers numerous advantages, both clinically and statistically, over the aggregate data approach.1 2 We outline when and how to initiate an individual participant data meta-analysis, the statistical issues in conducting one, how the findings should be reported, and what challenges this approach may bring.
What are individual participant data?
The term “individual participant data” relates to the data recorded for each participant in a study. In a hypertension trial, for example, the individual participant data could be the pre-treatment and post-treatment blood pressure, a treatment group indicator, and important baseline clinical characteristics such as age and sex, for each patient in each study (table⇓). A set of individual participant data from multiple studies often comprises thousands of patients; this is the case in the table, so for brevity we do not show all rows of data …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record







CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Ventilator associated pneumonia
Published 30 May 2012
Re: Restless legs syndrome
Published 30 May 2012
Author's reply
Published 30 May 2012
Re: Full access to trial data holds many benefits and a few pitfalls, conference hears
Published 30 May 2012
Restless Legs Syndrome: Fact or Fiction
Published 30 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (9 responses)
Published 2 May 2012 - 15:42
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27